Hydrogels to modulate lentivirus delivery in vivo from microporous tissue engineering scaffolds

被引:0
|
作者
Misael O. Avilés
Lonnie D. Shea
机构
[1] Northwestern University,Department of Chemical and Biological Engineering
[2] Northwestern University,Robert H. Lurie Comprehensive Cancer Center
[3] Northwestern University,Chemistry of Life Processes Institute
[4] Northwestern University,Institute for BioNanotechnology in Advanced Medicine
关键词
Biomaterial scaffolds; Hydrogels; Collagen; Fibrin; Alginate; Lentivirus;
D O I
暂无
中图分类号
学科分类号
摘要
Numerous strategies to induce tissue regeneration employ scaffolds to create space and present biological cues that promote development. In this report, microporous scaffolds that provide structural support were filled with hydrogels to regulate cell adhesion and migration and were investigated as delivery vehicles for gene therapy vectors in vivo. Porous scaffolds were filled with either lentivirus-entrapped collagen or fibrin hydrogels, both of which support cell adhesion yet have varied rates for degradation and cell infiltration. Empty scaffolds and alginate hydrogels were employed as controls, with the latter not supporting cell infiltration. Hydrogel-filled scaffolds retained the lentivirus more effectively than empty scaffolds, and transgene expression was observed for all scaffold conditions. Empty and fibrin-filled scaffolds had maximal transgene expression in vivo, followed by collagen and alginate, with similar levels. Transduced macrophages and dendritic cells were initially present at the scaffold boundary and adjacent tissue and within the scaffold at later time points for all but the alginate condition. At days 3 and 7, expression was also imaged throughout the spleen and thymus, which may result from cell migration from the implant. These studies demonstrate that hydrogels can modulate gene delivery from scaffolds used in cell transplantation and regenerative medicine.
引用
收藏
页码:91 / 101
页数:10
相关论文
共 50 条
  • [1] Hydrogels to modulate lentivirus delivery in vivo from microporous tissue engineering scaffolds
    Aviles, Misael O.
    Shea, Lonnie D.
    DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 2011, 1 (01) : 91 - 101
  • [2] Lentivirus delivery by adsorption to tissue engineering scaffolds
    Shin, Seungjin
    Salvay, David M.
    Shea, Lonnie D.
    JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2010, 93A (04) : 1252 - 1259
  • [3] Gene delivery from polymer scaffolds for tissue engineering
    Jang, JH
    Houchin, TL
    Shea, LD
    EXPERT REVIEW OF MEDICAL DEVICES, 2004, 1 (01) : 127 - 138
  • [4] Drug delivery from polymeric scaffolds for tissue engineering
    Shalkesheff, K.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2007, 59 : A76 - A76
  • [5] Thermosensitive Hydrogels as Scaffolds for Cartilage Tissue Engineering
    Zhang, Yanbo
    Yu, Jiakuo
    Ren, Kaixuan
    Zuo, Jianlin
    Ding, Jianxun
    Chen, Xuesi
    BIOMACROMOLECULES, 2019, 20 (04) : 1478 - 1492
  • [6] α-Helical peptide hydrogels as tissue engineering scaffolds
    Mehrban, N.
    Mullen, L. M.
    Abelardo, E. S.
    Branwell, E. L.
    Birchall, M. A.
    Woolfson, D. N.
    INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 2011, 92 (06) : A9 - A9
  • [7] Cellulose nanofibril hydrogels as scaffolds for tissue engineering
    Syverud, Kristin
    Heggset, Ellinor
    Rashad, Ahmad
    Mustafa, Kamal
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 255
  • [8] Plant virus incorporated hydrogels as scaffolds for tissue engineering possess low immunogenicity in vivo
    Luckanagul, Jittima Amie
    Lee, L. Andrew
    You, Shaojin
    Yang, Xiaoming
    Wang, Qian
    JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2015, 103 (03) : 887 - 895
  • [9] Hydrogels for protein delivery in tissue engineering
    Censi, Roberta
    Di Martino, Piera
    Vermonden, Tina
    Hennink, Wim E.
    JOURNAL OF CONTROLLED RELEASE, 2012, 161 (02) : 680 - 692
  • [10] Plasmid delivery in vivo from porous tissue-engineering scaffolds:: Transgene expression and cellular Transfection
    Jang, JH
    Rives, CB
    Shea, LD
    MOLECULAR THERAPY, 2005, 12 (03) : 475 - 483